Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Weber

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|June 24, 2010
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instabilityYan Degenhardt, Joel Greshock, Sylvie Laquerre, et al.
Community Genetics|July 9, 2004
The Cancer Genetics Network: recruitment results and pilot studiesHoda Anton-Culver, Argyrios Ziogas, Deborah Bowen, et al.
Cancer|October 10, 2003
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinomaWilliam D Foulkes, Kelly Metcalfe, Wedad Hanna, et al.
International Journal of Cancer|April 20, 2004
Smoking and the risk of breast cancer among carriers of BRCA mutationsParviz Ghadirian, Jan Lubinski, Henry Lynch, et al.
International Journal of Cancer|July 21, 2005
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriersAndré Nkondjock, Parviz Ghadirian, Joanne Kotsopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|June 24, 2010
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instabilityYan Degenhardt, Joel Greshock, Sylvie Laquerre, et al.
Community Genetics|July 9, 2004
The Cancer Genetics Network: recruitment results and pilot studiesHoda Anton-Culver, Argyrios Ziogas, Deborah Bowen, et al.
Cancer|October 10, 2003
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinomaWilliam D Foulkes, Kelly Metcalfe, Wedad Hanna, et al.
International Journal of Cancer|April 20, 2004
Smoking and the risk of breast cancer among carriers of BRCA mutationsParviz Ghadirian, Jan Lubinski, Henry Lynch, et al.
International Journal of Cancer|July 21, 2005
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriersAndré Nkondjock, Parviz Ghadirian, Joanne Kotsopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Pageof 7